These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5509968)

  • 1. Electromyographic tests for the evaluation of effects of myotonolytic drugs in muscular reflexogenic hyperreflexive states.
    Bonne A; Heymans W; Rosselle N
    Electromyography; 1970; 10(3):219-25. PubMed ID: 5509968
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of a new centrally acting muscle relaxant (RJ-64).
    Leszkovszky GP; Tardos L
    Arzneimittelforschung; 1970 Nov; 20(11):1778-83. PubMed ID: 4321623
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of new s-triazolobenzododiazepine (D-40TA) and other central muscle relaxants on spinal and supraspinal reflexes in cats.
    Chiba S; Nagawa Y
    Jpn J Pharmacol; 1973 Feb; 23(1):83-96. PubMed ID: 4541621
    [No Abstract]   [Full Text] [Related]  

  • 4. Parafon Forte tablets: a review of the literature.
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):123-6. PubMed ID: 806426
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of electromyographic studies with central muscle relaxants--feasibility of objectivization and standardization].
    Ollinger H; Gruber J; Singer F
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1985 Jun; 16(2):104-7. PubMed ID: 3930209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of an acetaminophen-chlorzoxazone combination (parafon forte) in the treatment of acute musculoskeletal disorders.
    Walker JM
    Curr Ther Res Clin Exp; 1973 May; 15(5):248-52. PubMed ID: 4196784
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind evaluation of Parafon Forte in the treatment of musculo-skeletal back conditions.
    Vernon WG
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):801-6. PubMed ID: 4629819
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacologic properties of 6-aminomethaqualone, a new quinazolinone compound with myotonolytic activity].
    Roesch E; Roesch A; Hofrichter G; Schenk G
    Arzneimittelforschung; 1971 Mar; 21(3):362-6. PubMed ID: 5107973
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new method for the study of muscle relaxation].
    Tassonyi E; Labancz K; Rózsa I; Vimláti L; Vimláti P
    Orv Hetil; 1971 Sep; 112(37):2216-8. PubMed ID: 5127592
    [No Abstract]   [Full Text] [Related]  

  • 10. [Central effect of new acyl- and aminomethyl benzoxazolone-2 derivatives].
    Kolasa K; Kleinrok Z
    Acta Pol Pharm; 1979; 36(3):383-91. PubMed ID: 517147
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the myotonolytic activity of tizanidine, eperisone and afloqualone in mouse and rabbit.
    Coward DM; White TG
    J Int Med Res; 1989; 17(4):358-62. PubMed ID: 2792555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology of 5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole (DS 103-282), a novel myotonolytic agent.
    Sayers AC; Bürki HR; Eichenberger E
    Arzneimittelforschung; 1980; 30(5):793-803. PubMed ID: 7190422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electromyographic method for objective measurement of muscle relaxant drugs.
    PETERSON CR; WISE CS
    Arch Phys Med Rehabil; 1961 Aug; 42():566-72. PubMed ID: 13734825
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preliminary pharmacological investigation of five new derivatives of benzoxazolone (author's transl)].
    Kruszewska A; Modzelewski J; Tamborska E; Langwiński R
    Ann Univ Mariae Curie Sklodowska Med; 1977; 32():261-71. PubMed ID: 614806
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of some central muscle relaxants on spinal cord reflex].
    Yoshino T
    Masui; 1971 Feb; 20(2):127-34. PubMed ID: 5101999
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of a new steroid relaxant, pavulon, in clinical practice].
    Ruzaĭkina TI; Solovova LE
    Eksp Khir Anesteziol; 1973; 18(6):64-7. PubMed ID: 4789270
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the two-phase therapy of degenerative rheumatism with a myotonolytic-antiphlogistic and an analgesic combination preparation].
    Frank O; Klemmayer K
    Praxis; 1968 Aug; 57(34):1173-5. PubMed ID: 5756690
    [No Abstract]   [Full Text] [Related]  

  • 18. Centrally acting skeletal-muscle relaxants.
    Domino EF
    Arch Phys Med Rehabil; 1974 Aug; 55(8):369-73. PubMed ID: 4850933
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic agents for reduction of heightened muscle tonus and increased reflex activity (centrally acting muscle relaxants)].
    Streller I
    Arzneimittelforschung; 1981; Suppl 27():71-2. PubMed ID: 7197941
    [No Abstract]   [Full Text] [Related]  

  • 20. [Simple methods for the pharmacologic differentiation of central muscle relaxants].
    Hofrichter G; Roesch A; Roesch E; Schenk G
    Arzneimittelforschung; 1967 Feb; 17(2):242-5. PubMed ID: 5631491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.